Article de revue
Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso—Implications for introduction of PsA-TT into the Expanded Programme on Immunization
A new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization campaign targeting 1–29 year olds was conducted in Burkina Faso in December 2010. Protection of subsequent infant cohorts will be necessary through either introduction of PsA-TT into the routine Expanded Programme on Immunization (EPI) or periodic repeat mass vaccination campaigns.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
Vaccine
Volume
33
Numéro
12
Type
Article de revue
Catégories
- Gestion de programme
Maladies
- Rougeole
- Méningite à méningocoques
Pays
- Burkina Faso
Mots-clés
- Suivi de la couverture
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région africaine
